|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,653.45 INR | +1.68% |
|
+5.58% | +7.39% |
EPS & Dividend: GlaxoSmithKline Pharmaceuticals Limited
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 30 | 32 | 32 | 42 | 57 | 29.5 | 29.5 |
| Rate of return | 1.8% | 2.42% | 1.65% | 1.46% | 2.5% | 1.11% | 1.11% |
| EPS 2 | 100 | 36.05 | 34.83 | 54.76 | 61.15 | 67.9 | 76.48 |
| Distribution rate | 30% | 88.8% | 91.9% | 76.7% | 93.2% | 43.4% | 38.6% |
| Reference price 2 | 1,662.95 | 1,324.15 | 1,943.10 | 2,877.30 | 2,283.40 | 2,653.45 | 2,653.45 |
| Nbr of stocks (in thousands) | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | 169,406 | - |
| Announcement Date | 16/05/22 | 17/05/23 | 17/05/24 | 13/05/25 | 13/05/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: GlaxoSmithKline Pharmaceuticals Limited
| 29/05/2026 | Ex-dividend date - 57 INR | 05:00 |
Upcoming Events: GlaxoSmithKline Pharmaceuticals Limited
| 03/08/2026 | Présentation aux Actionnaires / Analystes | Day | |
| 03/08/2026 | Board of Directors Meeting | Day | |
| 03/08/2026 | Earnings release | Q1 2027 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 1.11% | 1.11% | 39.08x | 17.12x | - | |
| 0.59% | 0.65% | 35.03x | 20.84x | 12.19x | |
| 2.1% | 2.2% | 27.48x | 6.98x | 6.29x | |
| 2.76% | 2.88% | 32.57x | 912.51x | 7.42x | |
| 2.83% | 2.89% | 19.7x | 7.05x | 4.68x | |
| 1.96% | 2.07% | 21.76x | 4.89x | 4.48x | |
| 3.71% | 3.62% | 13.48x | 5.84x | 5.05x | |
| 2.62% | 2.77% | 25.29x | 19.43x | 6.61x | |
| 2.53% | 2.62% | -46.92x | 8.23x | 5.63x | |
| 6.88% | 6.95% | 12.69x | 1.62x | 3.11x | |
| Average | 2.71% | 2.78% | 18.02x | 100.45x | 6.16x | |
| Weighted average by Cap. | 2.14% | 2.22% | 24.07x | 128.78x | 7.68x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
